TAKEDA PHARMACEUTICAL COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 4502 for the last quarter is 1.11 T JPY, and it's 6.53% higher compared to the previous quarter. The net income of Q3 23 is 105.72 B JPY.